Federal Circuit Sends Challenge Of Medtronic Patents Back To Board
WASHINGTON, D.C. — The Patent Trial and Appeal Board wrongly rejecting in full an inter partes review (IPR) petitioner’s claim that two Medtronic Inc. neurostimulation patents are obvious, the Federal Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article